Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Krish Patel, Michael B. Maris, Bruce D. Cheson, Jeffrey A. Zonder, Alexander M. Lesokhin, Gottfried Von Keudell, Erlene Kuizon Seymour, Gloria H.Y. Lin, Tina Catalano, Yaping Shou, Swaminathan Padmanabhan Iyer, Radhakrishnan Ramchandren | ||||||||||||
Title | Ongoing, first-in-human, phase I dose escalation study of the investigational CD47-blocker TTI-622 in patients with advanced relapsed or refractory lymphoma. | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/188624/abstract | ||||||||||||
Abstract Text | J Clin Oncol 38: 2020 (suppl; abstr 3030), DOI: 10.1200/JCO.2020.38.15_suppl.3030 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|